These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 34528760)

  • 1. Modeling glioblastoma heterogeneity as a dynamic network of cell states.
    Larsson I; Dalmo E; Elgendy R; Niklasson M; Doroszko M; Segerman A; Jörnsten R; Westermark B; Nelander S
    Mol Syst Biol; 2021 Sep; 17(9):e10105. PubMed ID: 34528760
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New insights for precision treatment of glioblastoma from analysis of single-cell lncRNA expression.
    Meng Q; Zhang Y; Li G; Li Y; Xie H; Chen X
    J Cancer Res Clin Oncol; 2021 Jul; 147(7):1881-1895. PubMed ID: 33693962
    [TBL] [Abstract][Full Text] [Related]  

  • 3. "Zooming in" on Glioblastoma: Understanding Tumor Heterogeneity and its Clinical Implications in the Era of Single-Cell Ribonucleic Acid Sequencing.
    Khalafallah AM; Huq S; Jimenez AE; Serra R; Bettegowda C; Mukherjee D
    Neurosurgery; 2021 Feb; 88(3):477-486. PubMed ID: 32674143
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modeling glioblastoma invasion using human brain organoids and single-cell transcriptomics.
    Krieger TG; Tirier SM; Park J; Jechow K; Eisemann T; Peterziel H; Angel P; Eils R; Conrad C
    Neuro Oncol; 2020 Aug; 22(8):1138-1149. PubMed ID: 32297954
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gene signatures of quiescent glioblastoma cells reveal mesenchymal shift and interactions with niche microenvironment.
    Tejero R; Huang Y; Katsyv I; Kluge M; Lin JY; Tome-Garcia J; Daviaud N; Wang Y; Zhang B; Tsankova NM; Friedel CC; Zou H; Friedel RH
    EBioMedicine; 2019 Apr; 42():252-269. PubMed ID: 30952620
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tracking intratumoral heterogeneity in glioblastoma via regularized classification of single-cell RNA-Seq data.
    Lopes MB; Vinga S
    BMC Bioinformatics; 2020 Feb; 21(1):59. PubMed ID: 32070274
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An Integrative Model of Cellular States, Plasticity, and Genetics for Glioblastoma.
    Neftel C; Laffy J; Filbin MG; Hara T; Shore ME; Rahme GJ; Richman AR; Silverbush D; Shaw ML; Hebert CM; Dewitt J; Gritsch S; Perez EM; Gonzalez Castro LN; Lan X; Druck N; Rodman C; Dionne D; Kaplan A; Bertalan MS; Small J; Pelton K; Becker S; Bonal D; Nguyen QD; Servis RL; Fung JM; Mylvaganam R; Mayr L; Gojo J; Haberler C; Geyeregger R; Czech T; Slavc I; Nahed BV; Curry WT; Carter BS; Wakimoto H; Brastianos PK; Batchelor TT; Stemmer-Rachamimov A; Martinez-Lage M; Frosch MP; Stamenkovic I; Riggi N; Rheinbay E; Monje M; Rozenblatt-Rosen O; Cahill DP; Patel AP; Hunter T; Verma IM; Ligon KL; Louis DN; Regev A; Bernstein BE; Tirosh I; Suvà ML
    Cell; 2019 Aug; 178(4):835-849.e21. PubMed ID: 31327527
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intratumoral heterogeneity: pathways to treatment resistance and relapse in human glioblastoma.
    Qazi MA; Vora P; Venugopal C; Sidhu SS; Moffat J; Swanton C; Singh SK
    Ann Oncol; 2017 Jul; 28(7):1448-1456. PubMed ID: 28407030
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Single cell-derived clonal analysis of human glioblastoma links functional and genomic heterogeneity.
    Meyer M; Reimand J; Lan X; Head R; Zhu X; Kushida M; Bayani J; Pressey JC; Lionel AC; Clarke ID; Cusimano M; Squire JA; Scherer SW; Bernstein M; Woodin MA; Bader GD; Dirks PB
    Proc Natl Acad Sci U S A; 2015 Jan; 112(3):851-6. PubMed ID: 25561528
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relapse pathway of glioblastoma revealed by single-cell molecular analysis.
    Chen X; Wen Q; Stucky A; Zeng Y; Gao S; Loudon WG; Ho HW; Kabeer MH; Li SC; Zhang X; Zhong JF
    Carcinogenesis; 2018 Jul; 39(7):931-936. PubMed ID: 29718126
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of the minimal residual disease state reveals distinct evolutionary trajectories of human glioblastoma.
    Qazi MA; Salim SK; Brown KR; Mikolajewicz N; Savage N; Han H; Subapanditha MK; Bakhshinyan D; Nixon A; Vora P; Desmond K; Chokshi C; Singh M; Khoo A; Macklin A; Khan S; Tatari N; Winegarden N; Richards L; Pugh T; Bock N; Mansouri A; Venugopal C; Kislinger T; Goyal S; Moffat J; Singh SK
    Cell Rep; 2022 Sep; 40(13):111420. PubMed ID: 36170831
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypoxia-inducible miR-196a modulates glioblastoma cell proliferation and migration through complex regulation of NRAS.
    Takkar S; Sharma V; Ghosh S; Suri A; Sarkar C; Kulshreshtha R
    Cell Oncol (Dordr); 2021 Apr; 44(2):433-451. PubMed ID: 33469841
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparative study of primary and recurrent human glioblastoma multiforme using the small animal imaging and molecular expressive profiles.
    Lin LT; Chiou SH; Lee TW; Liu RS; Hwang JJ; Chang CH; Ma HI; Lee YJ
    Mol Imaging Biol; 2013 Jun; 15(3):262-72. PubMed ID: 22948536
    [TBL] [Abstract][Full Text] [Related]  

  • 14. VDAC1 is a molecular target in glioblastoma, with its depletion leading to reprogrammed metabolism and reversed oncogenic properties.
    Arif T; Krelin Y; Nakdimon I; Benharroch D; Paul A; Dadon-Klein D; Shoshan-Barmatz V
    Neuro Oncol; 2017 Jul; 19(7):951-964. PubMed ID: 28339833
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combined acetyl-11-keto-β-boswellic acid and radiation treatment inhibited glioblastoma tumor cells.
    Conti S; Vexler A; Edry-Botzer L; Kalich-Philosoph L; Corn BW; Shtraus N; Meir Y; Hagoel L; Shtabsky A; Marmor S; Earon G; Lev-Ari S
    PLoS One; 2018; 13(7):e0198627. PubMed ID: 29969452
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Downregulated CLIP3 induces radioresistance by enhancing stemness and glycolytic flux in glioblastoma.
    Kang H; Lee S; Kim K; Jeon J; Kang SG; Youn H; Kim HY; Youn B
    J Exp Clin Cancer Res; 2021 Sep; 40(1):282. PubMed ID: 34488821
    [TBL] [Abstract][Full Text] [Related]  

  • 17. miR-124 and miR-137 inhibit proliferation of glioblastoma multiforme cells and induce differentiation of brain tumor stem cells.
    Silber J; Lim DA; Petritsch C; Persson AI; Maunakea AK; Yu M; Vandenberg SR; Ginzinger DG; James CD; Costello JF; Bergers G; Weiss WA; Alvarez-Buylla A; Hodgson JG
    BMC Med; 2008 Jun; 6():14. PubMed ID: 18577219
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A non-hierarchical organization of tumorigenic NG2 cells in glioblastoma promoted by EGFR.
    Al-Mayhani TF; Heywood RM; Vemireddy V; Lathia JD; Piccirillo SGM; Watts C
    Neuro Oncol; 2019 Jun; 21(6):719-729. PubMed ID: 30590711
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stem cell-associated heterogeneity in Glioblastoma results from intrinsic tumor plasticity shaped by the microenvironment.
    Dirkse A; Golebiewska A; Buder T; Nazarov PV; Muller A; Poovathingal S; Brons NHC; Leite S; Sauvageot N; Sarkisjan D; Seyfrid M; Fritah S; Stieber D; Michelucci A; Hertel F; Herold-Mende C; Azuaje F; Skupin A; Bjerkvig R; Deutsch A; Voss-Böhme A; Niclou SP
    Nat Commun; 2019 Apr; 10(1):1787. PubMed ID: 30992437
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MSI1 associates glioblastoma radioresistance via homologous recombination repair, tumor invasion and cancer stem-like cell properties.
    Lin JC; Tsai JT; Chao TY; Ma HI; Chien CS; Liu WH
    Radiother Oncol; 2018 Nov; 129(2):352-363. PubMed ID: 30322656
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.